Cargando…
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
INTRODUCTION: Glioblastoma multiforme (GBM) constitutes one of the deadliest tumors to afflict humans, although it is still considered an orphan disease. Despite testing multiple new and innovative therapies in ongoing clinical trials, the median survival for this type of malignancy is less than two...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714623/ https://www.ncbi.nlm.nih.gov/pubmed/34825292 http://dx.doi.org/10.1007/s11060-021-03902-8 |